Implementation of Smart Triage combined with a quality improvement program for children presenting to facilities in Kenya and Uganda: An interrupted time series analysis

J Mark Ansermino,Yashodani Pillay,Abner Tagoola,Cherri Zhang,Dustin Dunsmuir,Stephen Kamau,Joyce Kigo,Collins Agaba,Ivan Aine Aye,Bella Hwang,Stefanie K Novakowski,Charly Huxford,Matthew O. Wiens,David Kimutai,Mary Ouma,Ismail Ahmed,Paul Mwaniki,Florence Oyella,Emmanuel Tenywa,Harriet Nambuya,Bernard Opar Toliva,Nathan Kenya-Mugisha,Niranjan Kissoon,Samuel Akech
DOI: https://doi.org/10.1101/2024.02.09.24302601
2024-02-11
Abstract:Sepsis occurs predominantly in low-middle-income countries. Sub-optimal triage contributes to poor early case recognition and outcomes from sepsis. We evaluated the impact of Smart Triage using improved time to intravenous antimicrobial administration in a multisite interventional study. Smart Triage was implemented (with control sites) in Kenya (February 2021-December 2022) and Uganda (April 2020-April 2022). Children presenting to the outpatient departments with an acute illness were enrolled. A controlled interrupted time series was used to assess the effect on time from arrival at the facility to intravenous antimicrobial administration. Secondary analyses included antimicrobial use, admission rates and mortality ( ). During the baseline period, the time to antimicrobials decreased significantly in Kenya (132 and 58 minutes) at control and intervention sites, but less in Uganda (3 minutes) at the intervention site. Then, during the implementation period in Kenya, the time to IVA at the intervention site decreased by 98 min (57%, 95% CI 81-114) but increased by 49 min (21%, 95% CI: 23-76) at the control site. In Uganda, the time to IVA initially decreased but was not sustained, and there was no significant difference between intervention and control sites. At the intervention sites, there was a significant reduction in IVA utilization of 47% (Kenya) and 33% (Uganda), a reduction in admission rates of 47% (Kenya) and 33% (Uganda) and a 25% (Kenya) and 75% (Uganda) reduction in mortality rates compared to the baseline period. We showed significant improvements in time to intravenous antibiotics in Kenya but not Uganda, likely due to COVID-19, a short study period and resource constraints. The reduced antimicrobial use and admission and mortality rates are remarkable and welcome benefits but should be interpreted cautiously as these were secondary outcomes. This study underlines the difficulty of implementing technologies and sustaining quality improvement in health systems.
Emergency Medicine
What problem does this paper attempt to address?
The paper attempts to address the issue of improving the time from hospital arrival to receiving intravenous antibiotics for children with acute illnesses in healthcare facilities in Kenya and Uganda by implementing Smart Triage combined with quality improvement programs. Specifically, the study aims to evaluate whether the Smart Triage platform can shorten the time from patient arrival at the hospital to the initiation of intravenous antibiotics and to explore the impact of this intervention on patient outcomes, including reducing hospitalization rates, decreasing antibiotic usage, and lowering mortality rates. The research background points out that in low- and middle-income countries, particularly in sub-Saharan Africa, pediatric sepsis is a leading cause of preventable deaths. Delayed identification and treatment are significant barriers to reducing sepsis-related deaths and complications. Although traditional triage systems are widely adopted, their effectiveness in actual clinical practice is not ideal, necessitating new methods to improve triage and early treatment efficiency. The Smart Triage platform aims to optimize the identification and treatment processes for emergency patients through data-driven risk assessment, patient tracking, real-time monitoring, and automated reporting.